These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 21994957

  • 1. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
    Živičnjak M, Schnabel D, Staude H, Even G, Marx M, Beetz R, Holder M, Billing H, Fischer DC, Rabl W, Schumacher M, Hiort O, Haffner D, Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie.
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.
    Meyerhoff N, Haffner D, Staude H, Wühl E, Marx M, Beetz R, Querfeld U, Holder M, Billing H, Rabl W, Schröder C, Hiort O, Brämswig JH, Richter-Unruh A, Schnabel D, Živičnjak M, Hypophosphatemic Rickets Study Group of the “Deutsche Gesellschaft für Kinderendokrinologie und -diabetologie” and “Gesellschaft für Pädiatrische Nephrologie”.
    Pediatr Nephrol; 2018 Mar; 33(3):447-456. PubMed ID: 29058153
    [Abstract] [Full Text] [Related]

  • 3. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets.
    Zivičnjak M, Schnabel D, Billing H, Staude H, Filler G, Querfeld U, Schumacher M, Pyper A, Schröder C, Brämswig J, Haffner D, Hypophosphatemic Rickets Study Group of Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie.
    Pediatr Nephrol; 2011 Feb; 26(2):223-31. PubMed ID: 21120538
    [Abstract] [Full Text] [Related]

  • 4. Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
    Haffner D, Nissel R, Wühl E, Mehls O.
    Pediatrics; 2004 Jun; 113(6):e593-6. PubMed ID: 15173542
    [Abstract] [Full Text] [Related]

  • 5. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
    Rothenbuhler A, Esterle L, Gueorguieva I, Salles JP, Mignot B, Colle M, Linglart A.
    Growth Horm IGF Res; 2017 Oct; 36():11-15. PubMed ID: 28822957
    [Abstract] [Full Text] [Related]

  • 6. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, Jonsson B, Kriström B, Marcus C, Nilsson KO, Ritzén EM, Tuvemo T, Westphal O, Aman J.
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [Abstract] [Full Text] [Related]

  • 7. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [Abstract] [Full Text] [Related]

  • 8. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R, Martin DD, Schönau E, Ranke MB.
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone treatment improves final height in children with X-linked hypophosphatemia.
    André J, Zhukouskaya VV, Lambert AS, Salles JP, Mignot B, Bardet C, Chaussain C, Rothenbuhler A, Linglart A.
    Orphanet J Rare Dis; 2022 Dec 21; 17(1):444. PubMed ID: 36544157
    [Abstract] [Full Text] [Related]

  • 10. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov 21; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 11. Patterns of growth after kidney transplantation among children with ESRD.
    Franke D, Thomas L, Steffens R, Pavičić L, Gellermann J, Froede K, Querfeld U, Haffner D, Živičnjak M.
    Clin J Am Soc Nephrol; 2015 Jan 07; 10(1):127-34. PubMed ID: 25352379
    [Abstract] [Full Text] [Related]

  • 12. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ, Boonstra VH, Hokken-Koelega AC.
    Pediatrics; 2004 Sep 07; 114(3):683-90. PubMed ID: 15342839
    [Abstract] [Full Text] [Related]

  • 13. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar 07; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

  • 14. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
    Makitie O, Toiviainen-Salo S, Marttinen E, Kaitila I, Sochett E, Sipila I.
    Horm Res; 2008 Mar 07; 69(4):212-20. PubMed ID: 18204268
    [Abstract] [Full Text] [Related]

  • 15. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1999 May 07; 84(5):1558-61. PubMed ID: 10323379
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul 07; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 17. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR, Shim YS, Lee HS, Hwang JS.
    J Pediatr Endocrinol Metab; 2014 Jul 07; 27(7-8):629-33. PubMed ID: 24810558
    [Abstract] [Full Text] [Related]

  • 18. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R.
    J Clin Endocrinol Metab; 2007 Feb 07; 92(2):629-35. PubMed ID: 17090643
    [Abstract] [Full Text] [Related]

  • 19. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
    Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group.
    J Clin Endocrinol Metab; 2007 Jul 07; 92(7):2480-6. PubMed ID: 17356043
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
    Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA.
    J Clin Endocrinol Metab; 2007 Sep 07; 92(9):3406-16. PubMed ID: 17595258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.